P5E-10559-22112
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 916 / CA
- Registered
- 2021-08-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-02
Registered in v-safe
-
2021-08-02
Dose 1 — Pfizer-BioNTech
- 2021-08-02
- 2021-08-03
- 2021-08-04
- 2021-08-06
- 2021-08-07
- 2021-08-08
- 2021-08-11
-
2021-08-14
Dose 2 — Pfizer-BioNTech
- 2021-08-16
- 2021-08-19
- 2021-08-20
- 2021-08-21
- 2021-08-29
- 2021-09-04
-
2021-09-11
Survey response — day 28, dose 2MedDRA: Cough, Headache, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cough, congestion, headache.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-18
- 2021-09-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-02 | Pfizer-BioNTech | No |
| 2 | 2021-08-14 | Pfizer-BioNTech | No |
Free text
Release 9 — day 28, dose 2
Symptoms: Cough, congestion, headache.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release